I. Mykhaloiko and R. Yatsyshyn, “Apixaban versus warfarin in nephrotic syndrome: thromboembolic events, bleeding risk and changes in profibrotic and inflammatory cytokines”, Ukr. J. Nephrol. Dial., no. 2(90), pp. 20-31, Jun. 2026.